Officials at the Federal Reserve are divided about how to set the central bank's key interest rate in the coming months, and may not get the data they need to settle their differences anytime soon.
Candel Therapeutics has generated favorable phase 3 data supportive of a BLA submission in prostate cancer. Learn why CADL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback